TP53 and cancer: In the KEGG functional enrichment analysis (Supplementary Figure S8), differentially expressed proteins in the aloin-treated group were primarily enriched in several crucial pathways, including “Pathways in cancer,” “TGF-beta signaling pathway,” “Chemical carcinogenesis,” and “p53 signaling pathway” (Table 1).